A detailed history of Assetmark, Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Assetmark, Inc holds 231 shares of MRNA stock, worth $8,512. This represents 0.0% of its overall portfolio holdings.

Number of Shares
231
Previous 46,169 99.5%
Holding current value
$8,512
Previous $5.48 Million 99.73%
% of portfolio
0.0%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$63.64 - $125.14 $2.92 Million - $5.75 Million
-45,938 Reduced 99.5%
231 $15,000
Q2 2024

Aug 13, 2024

SELL
$101.21 - $166.61 $351,097 - $577,970
-3,469 Reduced 6.99%
46,169 $5.48 Million
Q1 2024

May 06, 2024

SELL
$85.37 - $115.44 $48.6 Million - $65.7 Million
-569,514 Reduced 91.98%
49,638 $5.29 Million
Q4 2023

Feb 09, 2024

BUY
$69.51 - $104.43 $28 Million - $42.1 Million
403,428 Added 187.01%
619,152 $61.6 Million
Q3 2023

Oct 27, 2023

BUY
$96.41 - $126.61 $4.6 Million - $6.04 Million
47,667 Added 28.36%
215,724 $22.3 Million
Q2 2023

Aug 11, 2023

SELL
$118.5 - $160.53 $36.7 Million - $49.7 Million
-309,310 Reduced 64.8%
168,057 $20.4 Million
Q1 2023

May 05, 2023

BUY
$135.66 - $197.02 $35.6 Million - $51.8 Million
262,782 Added 122.46%
477,367 $73.3 Million
Q4 2022

Feb 10, 2023

SELL
$118.38 - $210.04 $1.81 Million - $3.2 Million
-15,251 Reduced 6.64%
214,585 $38.5 Million
Q3 2022

Nov 01, 2022

BUY
$118.07 - $194.18 $258,927 - $425,836
2,193 Added 0.96%
229,836 $27.2 Million
Q2 2022

Aug 03, 2022

BUY
$117.13 - $176.59 $267,642 - $403,508
2,285 Added 1.01%
227,643 $32.5 Million
Q1 2022

May 13, 2022

BUY
$126.46 - $235.05 $23.6 Million - $43.9 Million
186,660 Added 482.35%
225,358 $38.8 Million
Q4 2021

Feb 14, 2022

BUY
$225.82 - $368.51 $8.68 Million - $14.2 Million
38,450 Added 15504.03%
38,698 $9.83 Million
Q3 2021

Nov 12, 2021

BUY
$221.9 - $484.47 $52,812 - $115,303
238 Added 2380.0%
248 $95,000
Q2 2021

Aug 16, 2021

BUY
$129.91 - $234.98 $1,299 - $2,349
10 New
10 $2,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Assetmark, Inc Portfolio

Follow Assetmark, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.